GSK RSV Ad - Search Videos

GlaxoSmithKline TV Spot, 'Cut Short by RSV: Showing Up'

GlaxoSmithKline TV Spot, 'Cut Short by RSV: Showing Up'

FDA Approves GSK’s RSV Vaccine for Older Adults

FDA Approves GSK’s RSV Vaccine for Older Adults

GlaxoSmithKline TV Spot, 'Cut Short by RSV'

GlaxoSmithKline TV Spot, 'Cut Short by RSV'

GlaxoSmithKline TV Spot, 'Cut Short by RSV: Outings'

GlaxoSmithKline TV Spot, 'Cut Short by RSV: Outings'

GSK - rsv commecial old people 60 cut for load green

GSK - rsv commecial old people 60 cut for load green

1K views9 months ago

YouTubeHarry little guy

RSV isn’t just a risk for kids - sponsored by GSK

RSV isn’t just a risk for kids - sponsored by GSK

RSV causes approximately 270,000 hospitalisations and 20,000 in-hospital deaths in adults aged 60 years and older in Europe each year. Although the symptoms of RSV infection are typically mild, older adults, and those with underlying medical conditions such as chronic heart and lung diseases, are at increased risk of severe infection. Find out how we’ve been trying to tackle RSV: https://gsk.to/3VqtTuV | GSK

RSV causes approximately 270,000 hospitalisations and 20,000 in-hospital deaths in adults aged 60 years and older in Europe each year. Although the symptoms of RSV infection are typically mild, older adults, and those with underlying medical conditions such as chronic heart and lung diseases, are at increased risk of severe infection. Find out how we’ve been trying to tackle RSV: https://gsk.to/3VqtTuV | GSK

864 viewsApr 27, 2023

GSK “Cut short by RSV” RSV and Me commercial (2023)

Our immune systems weaken as we age, making us more vulnerable to infections like respiratory syncytial virus (RSV), which can pose significant health risks. Hear how RSV impacted Peter’s life. | GSK

1.8M viewsAug 23, 2024

GSK : Arexvy associated with reductions in certain RSV-related risks including heart attack, stroke and severe flare-ups of COPD and asthma, real world study shows

marketscreener.com

FDA advisers recommend world's first RSV vaccines, from Pfizer and GSK

NBC NewsAria Bendix

GSK Shares Slump After CDC Narrows Age Recommendation for RSV Shots

GSK wins EU nod for RSV shot; Spire in early talks

marketscreener.com

Your risk of infection from respiratory syncytial virus (RSV) can increase due to certain conditions, like some ongoing illnesses or living in long-term care. How many of the below are you familiar with? Do you know someone who might be at risk of RSV? Learn more below 👇 or talk to your healthcare provider about how you can protect yourself and your loved ones from RSV | GSK

423 views7 months ago

GSK and Earvin “Magic” Johnson Partner to Raise Awareness of Risk of RSV in Older Adults

businesswire.com

Understanding respiratory syncytial virus means more than knowing the letters R-S-V. We are on a mission to help improve understanding about this leading cause of respiratory illness. At the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) this week, we will hear from respiratory and immunology experts: Dr Andrea Love and Prof Alberto Papi. Together, we are taking action to improve awareness, help reduce the burden of RSV and support better health outcom

3.2K viewsApr 9, 2025

Understanding respiratory syncytial virus means more than knowing the letters R-S-V. Take a minute to hear some facts about RSV from GSK colleagues and experts in vaccines and respiratory medicine 👇 | GSK

573 views7 months ago

GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up

marketscreener.com

GSK’s vaccine against RSV wins FDA approval - The Global Herald

theglobalherald.com

US FDA approves first RSV vaccine from GSK

marketscreener.com

GSK’s vaccine against RSV wins FDA approval

GSK: FDA Accepts Application To Review Expanded Use Of RSV Vaccine, Arexvy

finanznachrichten.de

Gsk Annonce Arexvy, Son Vaccin Contre Le Virus Respiratoire Syncytial (Rsv)...

Research and development | GSK

Battle of pharma giants: GSK sues Pfizer for patent infringement over RSV vaccine

GlaxoSmithKline TV Spot, 'VRS: trabajar'

GSK, RSV tedavisinde kullanılacak ilk aşı adayının Faz 3 sonuçlarını duyurdu | Sağlık Haberleri

8.3M viewsJul 13, 2022

GSK's RSV shot cleared in US for all adults #pharma #pharmanews #news

48 views1 month ago

YouTubepharmaphorum media limited

GSK stock falls as CDC shifts RSV vaccine recommendation

GSK's Race to Bring an RSV Vaccine to Market

See more